Activity of ancient viral genes may play a role in the development of multiple sclerosis (MS) and other neurological ...

Columnist Ben Hofmeister discusses the dual process model of coping and why allowing yourself to grieve can be part of a healthy process.

A pair of Phase 3 trials testing vidofludimus calcium in relapsing MS are continuing as planned after a positive committee ...

Large study of patients in 17 pivotal clinical trials finds need to treat MS by also treating other ills, from heart disease ...

Both modafinil and talk therapy offer mostly equivalent, clinically meaningful benefits for fatigue in people with multiple ...

Columnist Desiree Lama is grateful to have a kind and understanding partner, but stresses the importance of communication in ...

Sanofi stopped a Phase 2 study of oditrasertib in relapsing and progressive MS after it failed to lower blood NfL levels ...

Helius is opposing decisions on how much of the costs of its PoNS device for MS can be reimbursed under U.S. public health ...

The National MS Society has awarded $4.6 million in funding for five research projects aiming to help restore lost function ...

Transplanting genetically engineered OPCs, which give rise to myelin-making cells, boosted myelin repair in mice with brain ...

Curiously, columnist Leigh Anne Nelson can't tolerate wearing socks. It's one of several foot symptoms of her MS.

Adding Tecfidera to an immune tolerizing cell therapy could maximize therapeutic benefits for MS patients, according to a ...